An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial.

For the world’s web users, Vanderbilt University Medical Center is working with Google to address COVID-19 information gaps.

The IVY Research Network has completed initial studies evaluating the epidemiology of COVID-19 in health care workers and patients.

This week researchers at Vanderbilt University Medical Center (VUMC), the University of North Carolina at Chapel Hill and Gilead Sciences reported that remdesivir potently inhibited SARS-CoV-2, the virus which causes COVID-19, in human lung cell cultures and that it improved lung function in mice infected with the virus.

On March 27, Nashville resident Bill Boyce, 73, earned the unwelcome distinction of becoming the first patient intubated on Vanderbilt University Medical Center’s dedicated COVID-19 unit.

Due to COVID-19, used items are no longer accepted, but the need to help patients continues

Oh, beautiful for spacious distancing, with ample space between